Gene-to-drug proves to be a long and expensive route
Science passes another milestone with the publication on Monday of the first description of the human genome but the path to a new era of genomics-based medicine is proving longer and more costly
Science passes another milestone with the publication on Monday of the first description of the human genome but the path to a new era of genomics-based medicine is proving longer and more costly